KUN RUN BIOTECHNOLOGY, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 42.95B | ||||||
| 21.38B | ||||||
| 15.05B | ||||||
| 14.45B | ||||||
| 13.04B |
